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Background: In the United States, 6 of the 25 leading causes of death stem from site-specific cancers, resulting in over 1.7
million deaths annually. Yet, this burden is not evenly distributed. While the incidence of cancer is significantly higher in
urban areas, rural regions face higher rates of cancer mortality. Identifying the factors contributing rural cancer disparities can
facilitate more effective and feasible policy solutions.’
Problem Definition: Rural Americans are geographically isolated from high-quality cancer services and face systemic barriers
to NCI designated comprehensive cancer centers. Given this disparity, rural Americans have failed to fully realize the benefits
of expanded federal investment in improved cancer care. Efforts to increase the supply of rural oncologists have yielded
mixed results. Rather, this policy review identifies an opportunity to expand the capacity of America’s oncologists through
provider-to-provider telehealth models.
Methods: Federal and state statutes were scanned for telehealth legislation. CMS guidance relating to telehealth capacity
building were also reviewed. The tabulated political venues and policy activity were reported by branch and level of government.
Policy recommendations were then made by the focusing on states implementing provider-to-provider teleoncology models in
rural regions.
Policy Report: In 2016, Congress passed the Project ECHO Act which aimed to evaluate all provider-to-provider telehealth
capacity building models. However, the 2019 Project ECHO Act, which aimed to build upon the initial pilot, failed to progress
through the Senate. Most provider-to-provider teleoncology activity occurred at the state-level through Medicaid Waivers.
Conclusion: Neighboring states can build upon the success of these innovative healthcare delivery models by expanding the
diffusion of Medicaid waiver demonstrations which authorize reimbursement for provider-to-provider teleoncology in rural areas.
Keywords: cancer, telehealth, disparities, rural health, policy
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Cancer is the second leading cause of death in America
(Mokdad 2018). Six of the 25 leading causes of death
stem from site-specific cancers, resulting in over 1.7 mil-
lion deaths annually (Siegel, Miller, & Jemal, 2019). Yet,
this burden is not evenly distributed. While the inci-
dence of cancer is significantly higher in metro and urban
areas, rural regions face higher rates of cancer mortality
(Henley, 2017). This disparity pervades across multi-
ple cancers, including those responsible for the greatest
number of annual deaths (Figure 1). Identifying the fac-
tors contributing rural cancer disparities can facilitate
more effective and feasible policy solutions.’
PROBLEM DEFINITION
Rural health has been on the national agenda since
1990 (U.S. Congress 1990). Hospital closures, physi-
cian shortages, and limited technological capacity have
been identified as the major components of the health-
care inequity between rural and urban Americans (Hart-
ley, 2004; Ricketts, 2000). In the three decades that have
passed since, federal funding for cancer care and research
has increased dramatically, peaking during the Obama
Administration at $5 billion a year (Park 2016; ARRA
2009; Barlas, 2016). These expenditures, however, were
exclusively for National Cancer Institute (NCI) desig-
nated comprehensive cancer centers and largely allocated
for highly technical, specialized services (Park 2016).
Given the systemic barriers which prevent rural Ameri-
cans from accessing these comprehensive cancer centers,
rural Americans have failed to realize the benefits of ex-
panded federal investment and improved cancer care.
Rural Americans are geographically isolated from
high-quality cancer services. Depending on the definition
of rurality, 46 to 65 million Americans live in a rural area
(Ratcliffe 2018). Yet, all NCI designated comprehensive
cancer centers are in metropolitan counties, effectively
impeding access to the highest quality cancer care and
innovative treatment for millions of Americans (Institute
of Medicine 1989; National Academies of Sciences 2019).
While geography can be overcome, disparities persist
for the rural Americans with means to travel vast dis-
tances to access the cutting-edge cancer treatment. Ev-
idence is sparse, but in metropolitan counties with an
NCI designated cancer center, only 15% of Medicare Ad-
vantage plans include that center in network (Jacobson
2016). This metric serves as a strong proxy for the pro-
portion of private insurance plans in urban areas but
overestimates the likelihood of privately insured rural
adults with an NCI designated cancer center included
in the plan’s network (Jacobson 2016; Yasaitis 2017).
Further, the high cost associated with cancer care signif-
icantly increases as the distance from treatment increases
(Collado & Brownell, 2019; Zafar 2013). The evidence
linking financial burden and cancer survival outcomes
remains limited, but recent evidence has supported the
negative effects of increased financial burden on other
chronic disease outcomes (Murphy 2019; Nasir & Khera,
2019).
Receiving treatment at an NCI designated cancer cen-
ter returns considerable benefits, which cannot be under-
stated. One study investigated 51 different cancer cen-
ters to evaluate surgical outcomes in the Medicare pop-
ulation (Birkmeyer 2005). Post-operative mortality was
found to be significantly lower at NCI designated cancer
centers, with the disparity increasing with more com-
mon surgeries (Birkmeyer 2005). Another study con-
trolled for socioeconomic factors, such as residence, to
study patients at a Los Angeles cancer center (Wolfson
2015). This research showed 5% to 15% lower 5-year sur-
vival for patients receiving care outside of an NCI des-
ignated cancer center (Wolfson 2015). This same study
found that geographic factors were highly predictive of
receiving care at an NCI designated cancer center. All
else equal, living further than 9 miles away resulted in
a 40-60% reduction in the likelihood of receiving care
at a cancer center. Finally, a recent study found that
among academic institutions, the only predictor of im-
proved survival was receiving care at an NCI designated
center (Shulman 2017).
Despite clear benefits, the politics of NCI designa-
tion and the capital investment required to develop the
infrastructure limit the development of comprehensive
cancer centers outside of major academic institutions in
high-density metropolitan centers (Rubenson 16; Ruben-
son & Kapp, 2017; Rubenson 2019). While funded by
public grants, the cancer centers are primarily private,
tax-exempt institutions, which hold a monopoly over the
continued “war on cancer” and scientific breakthroughs
in treatment (Barker & Jordan, 2003). Without com-
petition, consumers lack the power to make healthcare
decisions on how to access the most appropriate care
(Roemer 1982). Not only is the market restricted, but
the growth in federal spending has created high-volume,
high-capital hospitals as an implicit requirement for en-
try (Weimer & Vining, 2017). The necessary economies
of scale to operate an NCI designated cancer center,
along with the “insider,” physician-driven designation
process presents itself as a failure of the free market, but
also a failure of governance (Hammer 2007).
These failures have intensified as the political and eco-
nomic power of rural America continues to deteriorate
(Parker 2018). However, health services research, alone,
rarely leads to policy development (Burris 2012; Folz
2005). By nature, Rural Americans represent a minority,
and are sparsely located throughout the country. Yet,
despite the factors minimizing this group’s collective ad-
vocacy, national and state leaders are paying attention
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to their continued story (Hall & Tolbert, 2018; Kaiser
Family Foundation, 2019). In addition to media and
presidential hopefuls putting rural health at the forefront
of political debate, this year’s Rural Health Day culmi-
nated by showcasing The Providers (2019), an award-
winning film documenting the frontlines of Rural Amer-
icans amidst the opioid crisis, hospital closures, and spe-
cialist shortages (AORH, 2019). In 2020, Rural Health
will be at the forefront of the political agenda.
PREVIOUS SOLUTION: INCREASE THE
SUPPLY OF RURAL PROVIDERS
THROUGH INCENTIVES.
In response to the market and governmental failures that
have isolated rural Americans from high-quality cancer
care, the federal government implemented a set of pro-
grams aiming to increase the supply of providers in rural
communities. Two prominent examples were the Physi-
cians for Underserved Areas Act, which waived J-1 visa
restrictions to encourage immigrant physicians to relo-
cate to high-need areas (2007), and Emergency Health
Personnel Act which created scholarship and loan for-
giveness programs for medical professionals committing
to practice in underserved regions (1970). This program
was later permanently reauthorized by the Patient Pro-
tection Affordable Care Act (2010). Rural cancer advo-
cates believed that by increasing the number of oncolo-
gists, rural patients would not only have greater access
to care, but the power dynamics and competition would
return to balance. While these policies accomplished
the goal of infusing rural areas with more providers, the
effect was minimal for cancer care, as most oncology
J1 visa slots go unfilled (Verma 2016). More so, even
when oncologists were placed, the programs failed to re-
tain providers past five years (Burris 2012; Kahn 2010).
Not only was the impact only marginally effective and
highly unsustainable, but arguably unjust from a global
perspective. These policies ultimately financed “brain
drain” , regressively redistributing providers from areas
of detrimental need (Dovlo, 2005). An update to the
J-1 Visa program is currently in the Senate Judiciary
Committee (Conrad State 30). Despite the bipartisan
support, the inefficiencies of this program relegate this
bill to a compliment, not a substitute, to innovative can-
cer control alternatives.
ALTERNATIVE PROPOSAL: INCREASE
THE CAPACITY OF RURAL PROVIDERS
THROUGH TELEONCOLOGY
Rather than increase the supply of providers or NCI des-
ignated sites, the reach of America’s greatest oncology
providers should be expanded through telehealth. Bet-
ter outcomes are associated with initial treatment at NCI
designated centers, but these hospitals are difficult to ac-
cess for rural Americans. The infeasibility of dramatic
expansion of NCI designated hospitals and unsustainable
efficacy of programs incentivizing rural oncology practice
has not impacted the disparity of rural cancer mortal-
ity. This growing disparity warrants immediate atten-
tion from policy makers (Figures 2-3).
This report presents a proposal to develop the capac-
ity of rural oncology service delivery by linking rural
hospitals and clinics via teleoncology with NCI desig-
nated comprehensive cancer centers, allowing patients
to receive equitable access to the highest-quality of can-
cer screening and treatment, without the added finan-
cial burden associated with travelling long distances or
out-of-pocket expenses from lack of in-network coverage.
This teleoncology proposal shifts rural cancer control to
an efficient allocation of resources for rural patients and
hospitals, but also for participating providers at NCI des-
ignated centers.
CURRENT POLICY ACTIVITY
In each of the three government branches, at both the
state and federal level, telehealth has held strong policy
precedent. America’s Federalist system of governance fa-
cilitates state-level variation, but also policy diffusion, in
addition to top-down models of centralized implementa-
tion (Robson, 1947). In the health system especially,
this interaction between levels and branches has dra-
matically increased in recent years (Thompson, 2013;
Weissert, 2008; Weissert 2017). The following cases,
bills, and executive actions showcase the emerging po-
litical venues where this teleoncology proposal can tran-
sition from agenda to policy, even amidst a highly parti-
san atmosphere within a seemingly divided government
(Sparer, 2011; Volden, 2017).
FEDERAL GOVERNMENT
Legislative
In 2016, then Senator Orin Hatch (UT-R) introduced a
bill which created a pilot program to enhance the ca-
pacity of telehealth specialists in health shortage areas,
typically rural communities, as defined by U.S. Code 42
254e. Signed by President Obama after considerable bi-
partisan support in both the house and congress, this
3-year pilot program called for a comprehensive evalu-
ation of the model’s effect. The Expanding Capacity
for Health Outcomes (ECHO) Act of 2016 “requires
the Department of Health and Human Services (HHS)
to report on technology-enabled collaborative learning
and capacity building models, which connect specialists
to primary care providers through videoconferencing to
facilitate case-based learning, dissemination of best prac-
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tices, and evaluation of outcomes.” (2016).
Executive
The model for the ECHO Act was initially designed by
the University of New Mexico as Project Echo (Arora
2007). Since its launch, this program has been dissem-
inated across the globe to care for diseases with wide-
ranging complexity and environmental barriers to tra-
ditional care (Zhou 2016). Until recently, Project Echo
has not penetrated the oncology sector. However, in
2014, MD Anderson, an NCI designated Comprehensive
Cancer Center, began the process to become the first
teleoncology “Super-Hub” (Satcher 2014).
STATE GOVERNMENT
Legislative
Since 2015, 235 telehealth bills have been enacted in 49
states (NCSL 2019). However, only one state (Wash-
ington) incorporated provider training within the scope
of telehealth legislation (WA S 5386 2019). In 2019,
the Washington State Senate passed a law which de-
tailed the necessary and appropriate training standards
for provider-to-provider telehealth practice. This bill
was introduced by a former hospital administrator, Sen-
ator Randi Becker, who served on the Ways and Means
committee and chaired the health care committee. The
governor signed this law, which took effect in July 2019.
Executive
One of the major contributors to enhanced state-to-state
variation in federal health policy implementation has
been the rise of executive Medicaid waivers (Sparer 2011
Fried 2014). While always in the purview of state au-
thority, only recently did federal congress delegate expe-
diated, targeted waiver approval powers to the President
(Morgan 2011). This has subsequently led to consid-
erable differences in how states manage their Medicaid
programs (Thompson & Burke, 2009).
Three states have utilized Medicaid waivers to autho-
rize reimbursement for provider-to-provider telehealth
models of service (CHCS 2017). The Center for Medi-
care and Medicaid Services (CMS) authorizes adminis-
trative or direct claims related to chronic disease man-
agement, as defined by SMDL #04-002 (2004). To mit-
igate substance abuse among its Medicaid beneficiaries,
Colorado created a Chronic Disease Accountable Care
Organization (ACO) which bills for provider education
from chronic disease specialists in Connecticut and Ari-
zona (Massey 2017). Similarly, Oregon and New Mexico
operate their Medicaid program under Managed Care
as granted by a 1115 waiver (CMS 2016; New Mexico
2016; Gaffney 2016). But while both states have taken
identical routes of implementation, Oregon focuses their
telehealth program to assist providers with psychiatric
medication management, while New Mexico extends spe-
cialized services throughout rural primary care networks
to lessen the burden related to travel (CHCS 2017).
POLICY MAKING OPPORTUNITIES
The presence of multiple political venues increases the
likelihood that this teleoncology proposal will translate
into policy. Given the current political environment, ty-
ing an agenda to a single branch or level of government
carries considerable risk. Rather, this review has identi-
fied three opportunities to advance teleoncology policies.
Goal 1: Pass the ECHO 2019 Act
The 2016 ECHO Act authorized the temporary evalua-
tion of provider-to-provider, telehealth models of service
delivery. No federal funds were allocated for expanding
these models and no technical assistance was provided to
facilitate their development. In February 2019, the final
report, which detailed the outcomes related to the 2016
pilot, were presented to congress (ASPE 20189). This
report highlighted the positive impact of the ECHO tele-
health model, but more importantly, showed the limited
reach across the country (Fischer 2019). The gaps signal
opportunities to grow this innovative program. Upon
submitting the report to Congress, a new bill authoriz-
ing grant provisions and technical assistance was drafted
by Senator Brian Schatz (HI-D) (ECHO 2019). Like its
predecessor, the 2019 bill has significant bipartisan sup-
port (Udall 2019). Despite the bipartisan nature, and
presence of high-profile cosponsors (Murkowski, Kaine,
Collins), this bill has not moved past its referral to the
Senate HELP committee. Instead, the language from
the ECHO Act has been adopted for the Lower Health
Care Costs Act (S.1895 2019). The authorization of
grants and technical capacity has been completely repli-
cated into the new bill. However, this act is much wider
in scope, and thus more expensive (CBO 2019). Yet,
this bill has bipartisan support and has since advanced
past the Senate HELP committee (Bluth 2019). Cur-
rently, this bill is on the general assembly calendar. Yet,
the considerable opposition from hospital interest groups
cast doubt on the act’s fate, making the ECHO Act’s at-
tachment to the grandiose Lower Health Care Costs Act
both a blessing and a curse (AHA 2019; AAMC 2019).
Goal 2: Increase access to teleoncology hubs
Despite the uncertain prospects of federal legislation, in-
creasing the utilization of provider-to-provider telehealth
programs remains popular among providers (AMA
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2019). Teleoncology, through “virtual hubs,” however
has not been widely practiced. The 2019 ECHO report
to congress indicates that only eight states have con-
ducted any provider-to-provider activity related to can-
cer. Further, most of these virtual hubs link to hospi-
tals outside of the U.S. (Fischer 2019). The Department
of Health and Human Services (HHS), which oversees
Medicare and Medicaid, in addition to the National Can-
cer Institute, could intervene to require hospitals with an
NCI designation to act as a virtual hub for in-state crit-
ical access hospitals, sole-community hospitals, or feder-
ally qualified health centers. HHS could also authorize
cross-state partnerships between high-need hospitals in
medically underserved areas and NCI designated cancer
centers.
The funding mechanism for this partnership would ini-
tially be driven by Medicare. Two options would exist
to facilitate the relationship between the participating
NCI designated cancer center and partner rural hospital.
The first would be Medicare revenue-sharing through a
global budget. This approach has shown efficacy as a
way of treating vulnerable, including rural, populations
with high-quality, efficient care (CAPH 2016; Sharfstein
2016 & 2017). The second mechanism would be to
create teleoncology as a reimbursable benefit for rural
Medicare Advantage plans. While Medicare Advantage
continues to grow in popularity, rural enrollment lags
(Kember 2015). Further, quality indicators for special-
ized services are heavily dependent upon the Medicare
Advantage plan network (Haeder 2019). Reimbursing
teleoncology via partnerships with NCI designated cen-
ters should encourage greater access to high-quality can-
cer services for seniors in-need and increase the value of
private Medicare Advantage plans in rural areas.
Goal 3: Expand teleoncology via Medicaid
(1115 Waivers)
Health policy does not always trickle down from the fed-
eral government. Innovative models of service delivery
and financing have also begun at the state level, with
the subsequent diffusion resulting in considerable state-
to-state variation or nation-wide implementation (Weis-
sert 2008; Thompson 2009). Nowhere has this expand-
ing state influence been more prominent than Medicaid
(Weissert 2017). Although Medicaid is a federal pro-
gram, states have authority over implementation and can
request waivers to reallocate or target existing programs.
It is this realm which the current teleoncology proposal
has the most potential for immediate implementation, as
the key features facilitating success (neighbor diffusion
and policy precedent) are present in the target states
(Imhof & Kaskie 2008; Nattinger 2016).
As discussed, three states currently authorize Medi-
caid reimbursement for ECHO models under managed
care programs (CHCS 2017). Six states have either cre-
ated a task force or have requested technical assistance
from the University of New Mexico to explore avenues
to implement a Medicaid Managed Care program which
could reimburse ECHO activities (Ibid.). Five of these
states: KS, MO, MT, NV, UT are the primary target for
this teleoncology proposal (Figure 4). Not only are these
five states showing interest in the innovative model but
are also neighbors to states which have already initiated
Medicaid Managed care with some cancer focus (CHCS
2017; Fischer 2019).
While the ACA was a highly partisan initiative, Med-
icaid Expansion turned out to be less so. A governor’s
political party did not perfectly determine the decision to
expand (KFF 2019). However, ideologically conservative
states were more likely to expand Medicaid via waiver
(Weissert 2017). These governors utilized Medicaid Ex-
pansion as a means of fulfilling a campaign healthcare
agenda, while also extending federally subsidized cov-
erage. This method of expanding and managing Med-
icaid has proliferated significantly, especially through
the Delivery System Reform Incentive Payment Program
(DSRIP) (Gates & Guyer, 2014).
DSRIP waivers are particularly attractive to states
aiming to control Medicaid costs through privatization.
This model is a primary target for the two states which
have not yet expanded Medicaid. Both Kansas and Mis-
souri can improve cancer outcomes by linking a greater
proportion of rural Medicaid enrollees to the in-state
NCI designated Cancer Centers. By expanding Medicaid
into a private managed care program, the 1115 waiver
allows the state to increase coverage and shift federal
funds to the private sector, allowing compromise for the
split governments of each state. The two states which
have already expanded, but do not have an in-state
NCI designated center should authorize ECHO reim-
bursement, but through the disease management model,
rather than service delivery. Nevada and Montana al-
ready have a case management waiver in place for their
Medicaid program, but neither explicitly targets cancer
as the chronic disease of interest. Yet, by establishing
an interstate partnership (similar the CO-CT partner-
ship mentioned above) the degree to which providers
can be reimbursed for managing Medicaid enrollees in-
creases, as does access to high-quality services for rural
residents. The final recommendation (Table 1) for Utah
differs due to the scope of the current waiver and pres-
ence of an in-state NCI designated cancer center. Utah’s
1115(c) waiver aims to increase technology utilization for
Medicaid-taking providers, allowing an easy transition to
an ECHO model. However, to further incentivize ECHO
participation for both the NCI designated cancer center
and rural providers, the 1115(c) waiver, under federal au-
thority SMDL #13-005, explicitly creates shared-savings
programs for all collaborating oncology specialists.
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Ending the current disparity between rural and urban
cancer mortality can best be accomplished by proliferat-
ing teleoncology throughout rural America. While this
state-level, Medicaid waiver approach may seem small in
scale, state-to-state diffusion can rapidly expand across
the country. The five states with documented inter-
est in ECHO models. near three state which are cur-
rently reimbursing ECHO through Medicaid, provide
a strong starting point. Colorado, the most interest-
ing model state given its rural makeup, political con-
text, and ECHO reimbursement, also manages 6 distinct
teleoncology platforms (Fischer 2019). These teleoncol-
ogy programs cover the entire spectrum of care, from
screening and treatment to survivorship and serve as an
excellent model of policy diffusion to surrounding rural
states. The similarities in key political (median state
senate ideology), institutional (policy innovativeness),
and governmental features (state taxation and expen-
ditures) between the model and target states support
the prediction that these teleoncology policy recommen-
dations will be successfully implemented (Klamer 2013;
Jordan 2017; Perkins 2019).
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Figure 1. Rural/Urban Cancer Disparities
The Rural : Urban Mortality Incidence Rate Disparity Ratio figures are calculated by dividing the mortality rate by the incidence rate for both
nonmetro and metro populations. The nonmetro mortality-to-incidence ratio (MIR) is then divided by the metro MIR. These cancers are in the 25
leading causes of mortality. Figure 1 shows the disparity between nonmetro MIR and metro MIR for all counties in the United States between 1999
and 2016. Box plots not crossing 1 indicate a significant disparity between nonmetro and metro counties (p < 0.05). Error bars indicate 99% C.I.
The MIR ratio provides a population-based indicator of survival disparities between 2 groups.
Source: United States Cancer Statistics - Mortality Incidence Rate Ratios: 1999-2016, WONDER Online Database. United States Department of Health












Figure 2. Rural/Urban Mortality since 1999
The Rural : Urban Mortality Incidence Rate Disparity Ratio figures are calculated by dividing the mortality rate by the incidence rate for both nonmetro
and metro populations. The nonmetro mortality-to-incidence ratio (MIR) is then divided by the metro MIR. These cancers listed in the 25 leading
causes of mortality. Figure 2 shows the change in disparity between nonmetro MIR and metro MIR from 1999 to 2016.Shaded regions represent the
95% confidence interval around the predicted value. Shaded regions not crossing 1 indicate a significant disparity between nonmetro/metro counties
(p < 0.05). The MIR ratio provides a population-based indicator of survival disparities between 2 groups.
Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research
Data, Nov 2018 Sub (1975-2016) ¡Katrina/Rita Population Adjustment¿ - Linked To County Attributes - Total U.S., 1969-2017 Counties, National
Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission.


































Figure 3. Five-Year Survival by Rural Continuum Code and Stage of Diagnosis
Figure 3 stratifies all U.S. cancer patients by Rural-Urban Continuum Codes, then compares the probability of 5-year survival for Local (1), Regional
(2), and Distant (3) diagnosis stages. These survival tables highlight the disparity in survival between metro, urban, and rural regions, regardless of
stage at diagnosis. “adj” indicates county is adjacent to a metro county. “notadj” indicates the county is NOT adjacent to a metro county.
Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research
Data, Nov 2018 Sub (1975-2016) ¡Katrina/Rita Population Adjustment¿ - Linked To County Attributes - Total U.S., 1969-2017 Counties, National













Figure 4. Medicaid Expansion and Project ECHO (Via Medicaid Managed Care) Map
Figure 4 shows all states by Medicaid Expansion status. Three states (CO, NM, OR) have authorized reimbursement of ECHO models under Medicaid
Managed Care. 6 states (HI, KS, MO, MT, NV, UT) have created task forces, working groups, or are receiving technical assistance to explore avenues
for creating a Medicaid Managed Care system which could also reimburse provider-to-provider telehealth models.
*Washington’s state legislature passed a bill authorizing the reimbursement for provider telehealth training.
Source: Center for Health Care Strategies Inc.










































Kansas No None University of Kansas Cancer
Center
Expand Medicaid via Private Managed Care
Waiver, authorizing ECHO reimbursement
through 1115 DSRIP Waiver, inking oncology
care for Medicaid enrollees to in-state NCI.
Shared Savings Optional.






Expand Medicaid by resubmitting Healthnet
Waiver, authorizing ECHO reimbursement
through 1115 DSRIP Waiver, linking oncology
care for Medicaid enrollees to in-state NCI.
Shared Savings Optional.
Montana Yes Case Management,
1915
Expires 2022
None Reauthorize waiver to include ECHO
reimbursement through Disease Management
Program (under federal authority SMDL
#04-002), linking oncology care to out of
state NCI (MD Anderson).
Nevada Yes None None Submit case management waiver for Medicaid,
which authorizes Disease Management ECHO
reimbursement (under federal authority
SMDL #04-002) and links Medicaid enrollees






Reauthorize current waiver to include ECHO
reimbursement under SPA Waiver (under
federal authority SMDL #13-005), linking
enrollees to in-state NCI through shared
savings program.
Table 1 shows the five target states and characteristics relevant to authorizing ECHO reimbursement under Medicaid.
Source(s):
1 Kaiser Family Foundation (2019)
2 Center for Medicare and Medicaid Services (2019) State Waiver List
3 National Cancer Institute (2019)
4 Center for Health Care Strategies Inc. (2017)
